Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IRIS positioning The White Iris white blood cell analyzer as replacement for manual microscopy.

This article was originally published in The Gray Sheet

Executive Summary

IRIS WILL ENTER HEMATOLOGY TESTING FIELD WITH THE WHITE IRIS, an automated high-speed leukocyte differential analyzer designed to classify normal, immature, and other abnormal white blood cells. Cleared through the 510(k) process May 13, The White Iris is scheduled for a late third-quarter limited roll-out to a number of "strategic" locations in the U.S., International Remote Imaging Systems says.

You may also be interested in...



IRIS Refocusing Energies On Urinalysis Market With Model 939 System

The first move by International Remote Imaging Systems (IRIS) in shifting its primary emphasis to the urinalysis market will be the launch of the Model 939 fully automated lab system immediately following expected 510(k) clearance at the end of the month.

Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking

Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel